The impact of the 340B Drug Pricing Program on Critical Access Hospitals : evidence from Medicare Part B
Dan Han
| Year of publication: |
2023
|
|---|---|
| Authors: | Han, Dan |
| Published in: |
Journal of health economics. - Amsterdam [u.a.] : Elsevier, ISSN 0167-6296, ZDB-ID 625797-5. - Vol. 89.2023, p. 1-30
|
| Subject: | 340B | Drug Pricing | Critical Access Hospitals | Cost-based reimbursement | Medicare | Krankenhaus | Hospital | Arzneimittel | Pharmaceuticals | Gesetzliche Krankenversicherung | Public health insurance | Gesundheitskosten | Health care costs | Preis | Price | Krankenhauskosten | Hospital costs | Arzneimittelmarkt | Pharmaceutical market | Krankenhausfinanzierung | Hospital financing |
| Type of publication: | Article |
|---|---|
| Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
| Language: | English |
| Other identifiers: | 10.1016/j.jhealeco.2023.102754 [DOI] |
| Source: | ECONIS - Online Catalogue of the ZBW |
Persistent link: https://www.econbiz.de/10014315980